VTYX
Ventyx Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.00
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-55.7%
Return on equity
-50.4%
Return on assets
-58.0%
Return on invested capital
0.00x
Asset turnover
-$87.8M
Cash from operations
$2.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025